Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Azd-7762. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 known ✓ | O14757 | 18/20 | 0.92 |
| ▸ | MELK | Q14680 | 3/20 | 0.92 |
| ▸ | PLK4 | O00444 | 1/20 | 0.92 |
| ▸ | GAK | O14976 | 1/20 | 0.92 |
| ▸ | JAK2 | O60674 | 1/20 | 0.92 |
| ▸ | ULK1 | O75385 | 1/20 | 0.92 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.92 |
| ▸ | STK10 | O94804 | 1/20 | 0.92 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.92 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.92 |
| ▸ | PAK4 | O96013 | 1/20 | 0.92 |
| ▸ | ABL1 | P00519 | 1/20 | 0.92 |
| ▸ | EGFR | P00533 | 1/20 | 0.92 |
| ▸ | LCK | P06239 | 1/20 | 0.92 |
| ▸ | FYN | P06241 | 1/20 | 0.92 |
| ▸ | FES | P07332 | 1/20 | 0.92 |
| ▸ | YES1 | P07947 | 1/20 | 0.92 |
| ▸ | LYN | P07948 | 1/20 | 0.92 |
| ▸ | RET | P07949 | 1/20 | 0.92 |
| ▸ | HCK | P08631 | 1/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azd-7762 SCHEMBL31517325 | 0.96 | CHEK1 (1.00) | CHEK1MELKPLK4GAKJAK2 | |
| Azd-7762 SCHEMBL1564574 | 0.96 | CHEK1 (1.00) | CHEK1MELKPLK4GAKJAK2 | |
| Azd-7762 SCHEMBL29388936 | 0.96 | CHEK1 (1.00) | CHEK1MELKPLK4GAKJAK2 | |
| Azd-7762 SCHEMBL15105420 | 0.96 | CHEK1 (1.00) | CHEK1MELKPLK4GAKJAK2 | |
| Azd-7762 SCHEMBL1127614 | 0.96 | CHEK1 (1.00) | CHEK1MELKPLK4GAKJAK2 | |
| Azd-7762 SCHEMBL19457662 | 0.95 | MELK (1.00) | CHEK1MELKPLK4GAKJAK2 | |
| Azd-7762 SCHEMBL29994838 | 0.95 | MELK (1.00) | CHEK1MELKPLK4GAKJAK2 | |
| SCHEMBL31532638 | 0.93 | CHEK1 (0.95) | CHEK1MELKPLK4GAKJAK2 | |
| SCHEMBL31532541 | 0.93 | CHEK1 (0.95) | CHEK1MELKPLK4GAKJAK2 | |
| SCHEMBL31532634 | 0.90 | CHEK1 (0.89) | CHEK1MELKPLK4GAKJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110112144-A1 | METHODS OF PREPARING SUBSTITUTED HETEROCYCLES | ASTRAZENECA AB (SE) | 2011-05-12 | — | — | US | disclosed |
| EP-2283012-A1 | METHODS OF PREPARING SUBSTITUTED HETEROCYCLES | AstraZeneca AB (SE) | 2011-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112144-A1 | METHODS OF PREPARING SUBSTITUTED HETEROCYCLES | HCCS, DPYD, TYMP | CHEK1 80/4885MELK 3335/4885PLK4 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.